Are drugmakers running out of familiar diseases to float to the public to sell drugs? (See: Have Drug; Need Patients!) Apparently so because Pfizer is now selling transthyretin amyloid cardiomyopathy in a new marketing campaign. Few can say it much less have ever heard of it. (Drugmakers call it ATTR-CM since they know that initialism More

The post New and Improved “Diseases” Launched by Drugmakers to Sell Drugs appeared first on CounterPunch.org.

This post was originally published on CounterPunch.org.